Vascular Access-Related Infections: Definitions, Incidence Rates, and Risk Factors

American Journal of Kidney Diseases

Volumn 52, Issue 5, 2008, Pages 982-993

  Lafrance, Jean Philippe ^a   Rahme, Elham ^a   Lelorier, Jacques ^b   Iqbal, Sameena ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

arteriovenous fistula; bacteremia; catheter related infections; Hemodialysis; vascular access

Indexed keywords

ACETYLSALICYLIC ACID;

BACTEREMIA; BLOOD CULTURE; CATHETER INFECTION; DIABETES MELLITUS; HEMODIALYSIS; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; PATHOGENESIS; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTEREMIA; BACTERIAL INFECTIONS; CATHETERS, INDWELLING; HUMANS; INCIDENCE; RENAL DIALYSIS; RISK FACTORS;

EID: 54149118593     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.06.014     Document Type: Review

References (86)

1. US Renal Data System. USRDS 2007 Annual Data Report (2007), The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
2. US Renal Data System. USRDS 2006 Annual Data Report (2006), The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
3. Berman S.J., Johnson E.W., Nakatsu C., Alkan M., Chen R., and LeDuc J. Burden of infection in patients with end-stage renal disease requiring long-term dialysis. Clin Infect Dis 39 (2004) 1747-1753
4. Elseviers M.M., and Van Waeleghem J.P. Identifying vascular access complications among ESRD patients in Europe. A prospective, multicenter study. Nephrol News Issues 17 (2003) 61-64 66-68, 99
5. Roberts T.L., Obrador G.T., St Peter W.L., Pereira B.J., and Collins A.J. Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients. Kidney Int 66 (2004) 2429-2436
6. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis 48 suppl 1 (2006) S248-S273
7. Pearson M.L. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: An overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 24 (1996) 262-277
8. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
9. Public Health Agency of Canada. Preventing infections associated with indwelling intravascular access device. Can Commun Dis Rep 23 suppl 8 (1997) 1-32
10. Allon M. Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis 44 (2004) 779-791
11. Poole C.V., Carlton D., Bimbo L., and Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: Effect of bacterial pathogen. Nephrol Dial Transplant 19 (2004) 1237-1244
12. Aslam N., Lambie M., Ayub V., and Stein A. Use of tunneled haemodialysis catheters at the start of haemodialysis-Success rates and definition of infection. Nephrol Dial Transplant 22 (2007) 1799-1800
13. Stevenson K.B., Adcox M.J., Mallea M.C., Narasimhan N., and Wagnild J.P. Standardized surveillance of hemodialysis vascular access infections: 18-Month experience at an outpatient, multifacility hemodialysis center. Infect Control Hosp Epidemiol 21 (2000) 200-203
14. Saeed Abdulrahman I., Al-Mueilo S.H., Bokhary H.A., Ladipo G.O., and Al-Rubaish A. A prospective study of hemodialysis access-related bacterial infections. J Infect Chemother 8 (2002) 242-246
15. Stevenson K.B., Hannah E.L., Lowder C.A., et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: Predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 39 (2002) 549-555
16. Tokars J.I., Miller E.R., and Stein G. New national surveillance system for hemodialysis-associated infections: Initial results. Am J Infect Control 30 (2002) 288-295
17. Jaber B.L. Bacterial infections in hemodialysis patients: Pathogenesis and prevention. Kidney Int 67 (2005) 2508-2519
18. Katneni R., and Hedayati S.S. Central venous catheter-related bacteremia in chronic hemodialysis patients: Epidemiology and evidence-based management. Nat Clin Pract Nephrol 3 (2007) 256-266
19. Kaplowitz L.G., Comstock J.A., Landwehr D.M., Dalton H.P., and Mayhall C.G. A prospective study of infections in hemodialysis patients: Patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol 9 (1988) 534-541
20. Marr K.A., Sexton D.J., Conlon P.J., Corey G.R., Schwab S.J., and Kirkland K.B. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 127 (1997) 275-280
21. Beathard G.A. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 10 (1999) 1045-1049
22. Saad T.F. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 34 (1999) 1114-1124
23. Little M.A., O'Riordan A., Lucey B., et al. A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant 16 (2001) 2194-2200
24. Dopirak M., Hill C., Oleksiw M., et al. Surveillance of hemodialysis-associated primary bloodstream infections: The experience of ten hospital-based centers. Infect Control Hosp Epidemiol 23 (2002) 721-724
25. Jean G., Charra B., Chazot C., et al. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron 91 (2002) 399-405
26. Krishnasami Z., Carlton D., Bimbo L., et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 61 (2002) 1136-1142
27. Taylor G., Gravel D., Johnston L., Embil J., Holton D., and Paton S. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 23 (2002) 716-720
28. Taylor G., Gravel D., Johnston L., Embil J., Holton D., and Paton S. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 32 (2004) 155-160
29. Develter W., De Cubber A., Van Biesen W., Vanholder R., and Lameire N. Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients. Artif Organs 29 (2005) 399-405
30. Sedlacek M., Gemery J.M., Cheung A.L., Bayer A.S., and Remillard B.D. Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am J Kidney Dis 49 (2007) 401-408
31. Hoen B., Paul-Dauphin A., Hestin D., and Kessler M. EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 9 (1998) 869-876
32. Tanriover B., Carlton D., Saddekni S., et al. Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies. Kidney Int 57 (2000) 2151-2155
33. Tokars J.I., Light P., Anderson J., et al. A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis 37 (2001) 1232-1240
34. Mokrzycki M.H., Zhang M., Cohen H., Golestaneh L., Laut J.M., and Rosenberg S.O. Tunnelled haemodialysis catheter bacteraemia: Risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant 21 (2006) 1024-1031
35. Lee O., Raque J.D., Lee L.J., Wivell W., Block C.A., and Bettmann M.A. Retrospective assessment of risk factors to predict tunneled hemodialysis catheter outcome. J Vasc Interv Radiol 15 (2004) 457-461
36. Centers for Disease Control and Prevention (CDC). Outbreaks of gram-negative bacterial bloodstream infections traced to probable contamination of hemodialysis machines-Canada, 1995; United States, 1997; and Israel, 1997. MMWR Morb Mortal Wkly Rep 47 (1998) 55-59
37. Wang S.A., Levine R.B., Carson L.A., et al. An outbreak of gram-negative bacteremia in hemodialysis patients traced to hemodialysis machine waste drain ports. Infect Control Hosp Epidemiol 20 (1999) 746-751
38. Saad T.F. Central venous dialysis catheters: Catheter-associated infection. Semin Dial 14 (2001) 446-451
39. Mokrzycki M.H., Schroppel B., von Gersdorff G., Rush H., Zdunek M.P., and Feingold R. Tunneled-cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virus. J Am Soc Nephrol 11 (2000) 2122-2127
40. Sexton D.J. Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. vii. Infect Dis Clin North Am 15 (2001) 731-742
41. Marr K.A., Kong L., Fowler V.G., et al. Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int 54 (1998) 1684-1689
42. Peacock S.J., Curtis N., Berendt A.R., Bowler I.C., Winearls C.G., and Maxwell P. Outcome following haemodialysis catheter-related Staphylococcus aureus bacteraemia. J Hosp Infect 41 (1999) 223-228
43. Engemann J.J., Friedman J.Y., Reed S.D., et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26 (2005) 534-539
44. Troidle L., Eisen T., Pacelli L., and Finkelstein F. Complications associated with the development of bacteremia with Staphylococcus aureus. Hemodial Int 11 (2007) 72-75
45. Berns J.S. Infection with antimicrobial-resistant microorganisms in dialysis patients. Semin Dial 16 (2003) 30-37
46. Appelbaum P.C. Microbiology of antibiotic resistance in Staphylococcus aureus. Clin Infect Dis 45 suppl 3 (2007) S165-S170
47. Klevens R.M., Morrison M.A., Nadle J., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298 (2007) 763-771
48. Shorr A.F. Epidemiology of staphylococcal resistance. Clin Infect Dis 45 suppl 3 (2007) S171-S176
49. Shurland S., Zhan M., Bradham D.D., and Roghmann M.C. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 28 (2007) 273-279
50. Finelli L., Miller J.T., Tokars J.I., Alter M.J., and Arduino M.J. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 18 (2005) 52-61
51. Hadley A.C., Karchmer T.B., Russell G.B., McBride D.G., and Freedman B.I. The prevalence of resistant bacterial colonization in chronic hemodialysis patients. Am J Nephrol 27 (2007) 352-359
52. Tokars J.I., Gehr T., Jarvis W.R., et al. Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers. Kidney Int 60 (2001) 1511-1516
53. Barbosa D., Lima L., Silbert S., et al. Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis. Am J Kidney Dis 44 (2004) 337-343
54. Atta M.G., Eustace J.A., Song X., Perl T.M., and Scheel Jr. P.J. Outpatient vancomycin use and vancomycin-resistant enterococcal colonization in maintenance dialysis patients. Kidney Int 59 (2001) 718-724
55. Fishbane S., Cunha B.A., Mittal S.K., Ruggian J., Shea K., and Schoch P.E. Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use. Infect Control Hosp Epidemiol 20 (1999) 461-462
56. Roghmann M.C., Fink J.C., Polish L., et al. Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients. Am J Kidney Dis 32 (1998) 254-257
57. Powe N.R., Jaar B., Furth S.L., Hermann J., and Briggs W. Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 55 (1999) 1081-1090
58. Weijmer M.C., Vervloet M.G., and ter Wee P.M. Compared to tunnelled cuffed haemodialysis catheters, temporary untunnelled catheters are associated with more complications already within 2 weeks of use. Nephrol Dial Transplant 19 (2004) 670-677
59. Kairaitis L.K., and Gottlieb T. Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant 14 (1999) 1710-1714
60. Maya I.D., and Allon M. Outcomes of tunneled femoral hemodialysis catheters: Comparison with internal jugular vein catheters. Kidney Int 68 (2005) 2886-2889
61. Bloembergen W.E., Stannard D.C., Port F.K., et al. Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int 50 (1996) 557-565
62. Allon M., Depner T.A., Radeva M., et al. Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO Study. J Am Soc Nephrol 14 (2003) 1863-1870
63. Nielsen J., Ladefoged S.D., and Kolmos H.J. Dialysis catheter-related septicaemia-Focus on Staphylococcus aureus septicaemia. Nephrol Dial Transplant 13 (1998) 2847-2852
64. Zimakoff J., Bangsgaard Pedersen F., Bergen L., et al. Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal-dialysis centres in Denmark. The Danish Study Group of Peritonitis in Dialysis (DASPID). J Hosp Infect 33 (1996) 289-300
65. Schwab S.J., Buller G.L., McCann R.L., Bollinger R.R., and Stickel D.L. Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use. Am J Kidney Dis 11 (1988) 166-169
66. Nassar G.M., and Ayus J.C. Infectious complications of the hemodialysis access. Kidney Int 60 (2001) 1-13
67. Zaleski G.X., Funaki B., Lorenz J.M., et al. Experience with tunneled femoral hemodialysis catheters. AJR Am J Roentgenol 172 (1999) 493-496
68. Verhallen A.M., Kooistra M.P., and van Jaarsveld B.C. Cannulating in haemodialysis: Rope-ladder or buttonhole technique?. Nephrol Dial Transplant 22 (2007) 2601-2604
69. Ball L.K., Treat L., Riffle V., Scherting D., and Swift L. A multi-center perspective of the buttonhole technique in the Pacific Northwest. Nephrol Nurs J 34 (2007) 234-241
70. Bonomo R.A., Rice D., Whalen C., Linn D., Eckstein E., and Shlaes D.M. Risk factors associated with permanent access-site infections in chronic hemodialysis patients. Infect Control Hosp Epidemiol 18 (1997) 757-761
71. Raju S. PTFE grafts for hemodialysis access. Techniques for insertion and management of complications. Ann Surg 206 (1987) 666-673
72. Curi M.A., Pappas P.J., Silva Jr. M.B., et al. Hemodialysis access: Influence of the human immunodeficiency virus on patency and infection rates. J Vasc Surg 29 (1999) 608-616
73. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis 48 suppl 1 (2006) S176-S247
74. Allon M. Current management of vascular access. Clin J Am Soc Nephrol 2 (2007) 786-800
75. Johnson D.W., MacGinley R., Kay T.D., et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 17 (2002) 1802-1807
76. Lok C.E., Stanley K.E., Hux J.E., Richardson R., Tobe S.W., and Conly J. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 14 (2003) 169-179
77. Johnson D.W., van Eps C., Mudge D.W., et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 16 (2005) 1456-1462
78. Boelaert J.R., Van Landuyt H.W., Godard C.A., et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant 8 (1993) 235-239
79. Kluytmans J.A., Manders M.J., van Bommel E., and Verbrugh H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 17 (1996) 793-797
80. Falagas M.E., Bliziotis I.A., and Fragoulis K.N. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: A systematic review of the evidence from comparative trials. Am J Infect Control 35 (2007) 106-114
81. Falagas M.E., Fragoulis K.N., and Bliziotis I.A. Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure-A meta-analysis of randomized controlled trials. Nephrol Dial Transplant 21 (2006) 2536-2542
82. Jaffer Y., Selby N.M., Taal M.W., Fluck R.J., and McIntyre C.W. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 51 (2008) 233-241
83. Yu V.L., Goetz A., Wagener M., et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 315 (1986) 91-96
84. Annigeri R., Conly J., Vas S., et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 21 (2001) 554-559
85. Deshpande L.M., Fix A.M., Pfaller M.A., and Jones R.N. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): Correlations of results from disk diffusion, Etest and reference dilution methods. Diagn Microbiol Infect Dis 42 (2002) 283-290
86. Bommer J., Vergetis W., Andrassy K., Hingst V., Borneff M., and Huber W. Elimination of Staphylococcus aureus in hemodialysis patients. ASAIO J 41 (1995) 127-131